Sino Biopharmaceutical SBHMY Stock
Sino Biopharmaceutical Price Chart
Sino Biopharmaceutical SBHMY Financial and Trading Overview
| Sino Biopharmaceutical stock price | 7.2 USD |
| Previous Close | 9.63 USD |
| Open | 9.63 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 9.63 - 9.63 USD |
| 52 Week Range | 9.22 - 12.76 USD |
| Volume | 65 USD |
| Avg. Volume | 1.21K USD |
| Market Cap | 9.06B USD |
| Beta (5Y Monthly) | 0.623754 |
| PE Ratio (TTM) | 28.32441 |
| EPS (TTM) | 0.28 USD |
| Forward Dividend & Yield | 0.41 (4.22%) |
| Ex-Dividend Date | June 20, 2023 |
| 1y Target Est | N/A |
SBHMY Valuation Measures
| Enterprise Value | 14.29B USD |
| Trailing P/E | 28.32441 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.31469044 |
| Price/Book (mrq) | 0.29889196 |
| Enterprise Value/Revenue | 0.496 |
| Enterprise Value/EBITDA | 2.117 |
Trading Information
Sino Biopharmaceutical Stock Price History
| Beta (5Y Monthly) | 0.623754 |
| 52-Week Change | -7.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.76 USD |
| 52 Week Low | 9.22 USD |
| 50-Day Moving Average | 10.27 USD |
| 200-Day Moving Average | 10.63 USD |
SBHMY Share Statistics
| Avg. Volume (3 month) | 1.21K USD |
| Avg. Daily Volume (10-Days) | 50 USD |
| Shares Outstanding | 940.46M |
| Float | 473.01M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.106 |
| Trailing Annual Dividend Yield | 1.10% |
| 5 Year Average Dividend Yield | 122.00% |
| Payout Ratio | 0.71650004 |
| Last Split Factor | 1.5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 8.83% |
| Operating Margin (ttm) | 20.43% |
| Gross Margin | 79.86% |
| EBITDA Margin | 23.45% |
Management Effectiveness
| Return on Assets (ttm) | 5.89% |
| Return on Equity (ttm) | 13.22% |
Income Statement
| Revenue (ttm) | 28.78B USD |
| Revenue Per Share (ttm) | 30.9 USD |
| Quarterly Revenue Growth (yoy) | 8.59% |
| Gross Profit (ttm) | N/A |
| EBITDA | 6.75B USD |
| Net Income Avi to Common (ttm) | 2.54B USD |
| Diluted EPS (ttm) | 0.34 |
| Quarterly Earnings Growth (yoy) | -89.79% |
Balance Sheet
| Total Cash (mrq) | 16.92B USD |
| Total Cash Per Share (mrq) | 18.33 USD |
| Total Debt (mrq) | 14.12B USD |
| Total Debt/Equity (mrq) | 37.21 USD |
| Current Ratio (mrq) | 1.287 |
| Book Value Per Share (mrq) | 32.22 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.27B USD |
| Levered Free Cash Flow (ttm) | 3.29B USD |
Profile of Sino Biopharmaceutical
| Country | United States |
| State | N/A |
| City | Wan Chai |
| Address | Unit 09, Office Tower |
| ZIP | N/A |
| Phone | 852 2802 9886 |
| Website | https://www.sinobiopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26272 |
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
Q&A For Sino Biopharmaceutical Stock
What is a current SBHMY stock price?
Sino Biopharmaceutical SBHMY stock price today per share is 7.2 USD.
How to purchase Sino Biopharmaceutical stock?
You can buy SBHMY shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sino Biopharmaceutical?
The stock symbol or ticker of Sino Biopharmaceutical is SBHMY.
Which industry does the Sino Biopharmaceutical company belong to?
The Sino Biopharmaceutical industry is Biotechnology.
How many shares does Sino Biopharmaceutical have in circulation?
The max supply of Sino Biopharmaceutical shares is 940.06M.
What is Sino Biopharmaceutical Price to Earnings Ratio (PE Ratio)?
Sino Biopharmaceutical PE Ratio is 25.71428500 now.
What was Sino Biopharmaceutical earnings per share over the trailing 12 months (TTM)?
Sino Biopharmaceutical EPS is 0.28 USD over the trailing 12 months.
Which sector does the Sino Biopharmaceutical company belong to?
The Sino Biopharmaceutical sector is Healthcare.